Tag: GSK

May 23, 2018

Providing Non-Exclusive Licenses Makes Zymeworks “Lucky,” Says CEO

The Investing News Network spoke with Zymeworks CEO Ali Tehrani at the Bloom Burton & Co. Health Care Conference, which...
April 19, 2018

NeuroMetrix Reports Q1 2018 Financial Results

NeuroMetrix (Nasdaq:NURO) reported financial and business highlights for the quarter ended March 31, 2018. As quoted in the press release:...
April 18, 2018

Biotech Update: Q1 2018 in Review

With Q1 2018 behind us, here the Investing News Network looks back on some of the biggest trends of the...
February 20, 2018

5 Pharmaceutical NASDAQ Micro-Cap Stocks

Many companies are taking advantage of partnerships and M&As, whereas others are looking to maximize their own sales by solely...
January 30, 2018

5 Top Biotech Stocks to Watch on the TSX in 2018

Whether you've been interested in biotech companies for a while, or just getting in the business, these companies are ones...
January 18, 2018

NeuroMetrix and GlaxoSmithKline will Collaborate to Develop and Expand Access to Quell Wearable Pain Relief Technology

NeuroMetrix, Inc. (Nasdaq:NURO) announced today a collaboration with GlaxoSmithKline (NYSE:GSK), one of the world’s largest science-led global healthcare companies, involving Quell® Wearable...
June 26, 2017

Q Biomed Inc. Adds Nuclear Medicine Industry Veteran to Commercialization Team

Q BioMed Inc. (OTCQB:QBIO), a biotechnology acceleration company, announced today that Christopher Manuele will join the Strontium 89 Chloride commercialization...